Results 91 to 100 of about 950 (122)

Association between hypocalcemia and rivaroxaban in coagulation disorders: a case report. [PDF]

Einstein (Sao Paulo), 2020
Pos AM, Aleixo MA, Drummond-Lage AP.
europepmc   +1 more source

Severe secondary hyperparathyroidism: an increasing problem in CKD but the best management option is still unknown. [PDF]

J Bras Nefrol
Tiong MKD, Toussaint ND.
europepmc   +1 more source

Prevalence of radiological findings among cases of severe secondary hyperparathyroidism. [PDF]

Sao Paulo Med J, 2009
Lacativa PG, Franco FM, Pimentel JR, Patrício Filho PJ, Gonçalves MD, Farias ML.   +5 more
europepmc   +1 more source

Optic nerve sheath calcification in a patient with chronic kidney disease: an unusual orbital manifestation. [PDF]

J Bras Nefrol
Mori LH, Ventura N, Corrêa DG.
europepmc   +1 more source

Translation into Portuguese (Brazil), cultural adaptation and validation of Parathyroid Assessment of Symptoms (PAS) in patients with chronic kidney disease and hyperparathyroidism. [PDF]

J Bras Nefrol
Campos RCE, Amaral RRD, Hentschke MR, Toneto MG, Poli-de-Figueiredo CE.   +4 more
europepmc   +1 more source

Update in Imaging Evaluation of Bone and Soft Tissue Sarcomas. [PDF]

Rev Bras Ortop (Sao Paulo), 2023
Guedes A, Oliveira MBDR, Melo AS, Carmo CCMD.   +3 more
europepmc   +1 more source

Assessment of hyperparathyroidism secondary to CKD beyond laboratory tests: the important validation of the Parathyroid Assessment of Symptom (PAS) questionnaire for Portuguese language (Brazil). [PDF]

J Bras Nefrol
Barreto FC, Santos CGDS.
europepmc   +1 more source

Brazilian Guidelines of Hypertension - 2020. [PDF]

Arq Bras Cardiol, 2021
Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, Machado CA, Poli-de-Figueiredo CE, Amodeo C, Mion Júnior D, Barbosa ECD, Nobre F, Guimarães ICB, Vilela-Martin JF, Yugar-Toledo JC, Magalhães MEC, Neves MFT, Jardim PCBV, Miranda RD, Póvoa RMDS, Fuchs SC, Alessi A, Lucena AJG, Avezum A, Sousa ALL, Pio-Abreu A, Sposito AC, Pierin AMG, Paiva AMG, Spinelli ACS, Nogueira ADR, Dinamarco N, Eibel B, Forjaz CLM, Zanini CRO, Souza CB, Souza DDSM, Nilson EAF, Costa EFA, Freitas EV, Duarte EDR, Muxfeldt ES, Lima Júnior E, Campana EMG, Cesarino EJ, Marques F, Argenta F, Consolim-Colombo FM, Baptista FS, Almeida FA, Borelli FAO, Fuchs FD, Plavnik FL, Salles GF, Feitosa GS, Silva GVD, Guerra GM, Moreno Júnior H, Finimundi HC, Back IC, Oliveira Filho JB, Gemelli JR, Mill JG, Ribeiro JM, Lotaif LAD, Costa LSD, Magalhães LBNC, Drager LF, Martin LC, Scala LCN, Almeida MQ, Gowdak MMG, Klein MRST, Malachias MVB, Kuschnir MCC, Pinheiro ME, Borba MHE, Moreira Filho O, Passarelli Júnior O, Coelho OR, Vitorino PVO, Ribeiro Junior RM, Esporcatte R, Franco R, Pedrosa R, Mulinari RA, Paula RB, Okawa RTP, Rosa RF, Amaral SLD, Ferreira-Filho SR, Kaiser SE, Jardim TSV, Guimarães V, Koch VH, Oigman W, Nadruz W.   +96 more
europepmc   +1 more source

Serum parathyroid hormone trajectory during the first year of hemodialysis: a roadmap to severe hyperparathyroidism. [PDF]

J Bras Nefrol
Duque EJ, Canziani MEF, Barra ABL, Dalboni MA, Strogoff-de-Matos JP, Elias RM, Moysés RMA.   +6 more
europepmc   +1 more source

Secondary hyperparathyroidism: what we know and what we are still learning. [PDF]

J Bras Nefrol
Litchteneker K, Bucharles SGE, Barreto FC.   +2 more
europepmc   +1 more source